Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

245 results about "Quinolizidines" patented technology

Saturated quinolizines that are two fused six-membered rings with a nitrogen atom at the ring fusion. They are biosynthesized in PLANTS by cyclization of a LYSINE coupled to CADAVERINE. Many of them are naturally occurring ALKALOIDS.

Quinoline compound and application thereof

The invention relates to the field of medicinal chemistry, in particular to quinoline compounds or pharmaceutically acceptable salts, isomers, solvates, compositions and medical application thereof. Pharmacological tests prove that the quinoline compound disclosed by the invention has a relatively good affinity effect on KRASG12D-cRaf. When the concentration is 10 M, the compound C1, the compound C3, the compound C4, the compound C6, the compound C11, the compound C12, the compound C13, the compound C16, the compound C22 and the compound C23 have a certain inhibition effect on KRASG12D-cRaf. Particularly, the compound C1 and the compound C12 both show a strong inhibition effect on KRASG12D-cRaf.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

Cation-dyeable polyester fiber structure, production method of the same, and uniform for medical use

To provide a cation-dyeable polyester fiber structure, a production method of the same, and a uniform for medical use.SOLUTION: A cation-dyeable polyester fiber structure includes a cationic dye, a quinoline compound, and an ultraviolet absorber, where 0.03 mass% or more and 0.80 mass% or less of the quinoline compound is included to a mass of the cation-dyeable polyester fiber structure, a color difference ΔE between before and after irradiating the cation-dyeable polyester fiber structure with ultraviolet carbon arc lamplight is 2.0 or lower, and an antibacterial activity value A50 after 50 times of high temperature acceleration washing is larger than a standard cloth growth value F in an antibacterial evaluation method described in an SEK mark textile product certification standard.SELECTED DRAWING: None
Owner:TORAY INDUSTRIES INC

Complex water quality flow-back fluid directly-prepared functional fracturing fluid

The invention discloses a functional fracturing fluid directly prepared from flow-back fluid of complex water quality. The fracturing fluid is prepared by directly adding a salt-tolerant polymer and an ion trapping agent into the flow-back fluid. The addition amount of the salt-tolerant polymer accounts for 0.15-0.3% of the total mass of the fracturing fluid, and the addition amount of the ion trapping agent is 100-500ppm. The salt-tolerant polymer is prepared by copolymerization of acrylamide, a salt-tolerant monomer and an allyl quinoline monomer, and the molecular weight of the polymer is 4-15 million. The salt-tolerant monomer is acrylamide polyoxyethylene sodium benzenesulfonate or acrylamide sodium sulfonate. The ion trapping agent is prepared from amino trimethylene phosphonic acid, diethylene triamine penta (methylene phosphonic acid), ethylene glycol bis (2-aminoethyl ether) tetraacetic acid, p-methylphenyl diethanol amine, 2, 3-epoxypropyl trimethyl ammonium chloride, fatty alcohol-polyoxyethylene ether, citric acid and tetrahydrofurfuryl acrylate. The fracturing fluid can be directly prepared from the flow-back fluid, the flow-back fluid does not need to be pretreated, and repeated utilization of the fracturing flow-back fluid is achieved.
Owner:CHENGDU LEARN PRACTICES TECH CO LTD

Cyanoquinoline-targeting protein degradation molecule, preparation method therefor and use thereof

PCT designated stage expiredWO2025011623A1Organic chemistryAntineoplastic agentsDiseaseProtein target
Provided are a cyanoquinoline-targeting protein degradation molecule, a preparation method therefor and a use thereof. Particularly, the present invention relates to a compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition comprising the compound, and a use of the compound as a protein degradation targeting chimera of an androgen receptor in preparation of medicaments for treating related diseases (including prostate cancer, breast cancer, and spinal and bulbar muscular atrophy) controlled by the androgen receptor, wherein the definitions of the substituents in general formula (I) are the same as those in the description.
Owner:SHANGHAI YIDI BIOTECHNOLOGY CO LTD

Trifluoromethyl-containing 3-spiroindoline derivative and preparation method thereof

The invention discloses a 3-spiroindoline derivative containing trifluoromethyl and a preparation method of the 3-spiroindoline derivative, and belongs to the technical field of organic synthesis. According to the invention, trifluoromethyl is introduced into a spiro [indoline-3, 3 '-quinoline] compound and a spiro [indoline-3, 3'-pyrrole] compound for the first time, a 3-(2-isocyano benzyl)-1H-indole derivative and a 3-(2-isocyano ethyl)-1H-indole derivative are used as raw materials, CF3Br is used as a fluorinating reagent, and the spiro [indoline-3, 3 '-quinoline] compound and the spiro [indoline-3, 3'-pyrrole] compound are synthesized under the action of visible light induction and a photocatalyst and alkali. The spiro [indoline-3, 3 '-quinoline] compound and the spiro [indoline-3, 3'-pyrrole] compound containing trifluoromethyl are prepared in one step through a free radical tandem cyclization dearomatization reaction, and the method has the characteristics of being green and safe, cheap and easily available in raw materials, high in atom economy, mild in reaction condition, wide in substrate application range, easy in product purification and the like, and belongs to green synthesis.
Owner:NORTHWEST NORMAL UNIVERSITY

Synthetic method of efficient polysubstituted pyrrolo [2, 1-a] isoquinoline compound

The invention relates to a synthetic method of an efficient polysubstituted pyrrolo [2, 1-a] isoquinoline compound, and discloses a method for synthesizing the polysubstituted pyrrolo [2, 1-a] isoquinoline compound by taking a 2-(3, 4-dihydroisoquinoline-2 (1H)-yl) malononitrile compound and 2, 3-dichloro-5, 6-dicyanobenzoquinone as oxidizing agents and substituted isocyano acetate under the action of a catalyst. The method has the advantages of cheap initial raw materials, mild reaction conditions and simple experimental operation, can save the investment of funds and labor force, and provides a simple and efficient preparation method for the polysubstituted pyrrole [2, 1-a] isoquinoline compound.
Owner:LANZHOU UNIV

Isoquinoline drugs and their use in improving or treating gastrointestinal tumors

The present application relates to the technical field of small molecule drugs, in particular to a isoquinoline drug and its application in improving or treating digestive tract tumors, and aims to provide a compound, a pharmaceutical composition containing the compound and its application in treating colorectal cancer and gastric cancer, and provides a 3,13-position substituted berberine derivative, the drug itself has less toxicity and does not affect the growth of normal human cells, and has a good application prospect in the development of novel antitumor drugs, especially in the development of anti-digestive tract tumor drugs.
Owner:HEFEI JUNYIDA BIOMEDICAL TECHNOLOGY CO LTD

Electrolyte and battery

PendingCN118943489AEasy to storeGood lithium conduction performanceSecondary cellsElectrolytic agentElectrical battery
The invention provides an electrolyte and a battery. The electrolyte comprises a lithium salt, an organic solvent, a carbonic ester additive and a first functional additive, according to the electrolyte, the quinoline compound additive containing-OLi is introduced, so that the electrolyte can directly participate in film formation of a positive electrode CEI, the uniformity and compactness of positive electrode film formation are effectively promoted, and the stability of a positive electrode interface is improved; and in addition, the electrolyte can act together with other additives such as a sulfur-containing additive and a carbonic ester additive, so that negative electrode SEI film formation is further promoted, and the interface stability of the negative electrode is improved.
Owner:EVE ENERGY CO LTD

Fiber structure and manufacturing method thereof

The present invention provides a fiber structure having excellent antibacterial properties and washing durability, and a method for producing the same. [Solution] A textile structure having polyamide fibers and containing a dye, a quinoline-based compound, and a phenol derivative, wherein the textile structure contains 0.04% by mass or more of the quinoline-based compound relative to the mass of the textile structure, and even after 10 standard washes in accordance with the "SEK Mark Textile Product Washing Method," the textile structure contains 0.04% by mass or more of the quinoline-based compound relative to the mass of the textile structure, and 0.20% by mass or more and 4.00% by mass or less of the phenol derivative relative to the mass of the textile structure.
Owner:TORAY INDUSTRIES INC

Preparation and purification method and application of quinoline derivative with biological activity

The invention discloses a preparation and purification method and application of a quinoline derivative with biological activity, and belongs to the technical field of medicine synthesis. According to the key points of the technical scheme, the quinoline derivative molecule has a structure # imgabs0 #, wherein X is NH or empty (benzene rings are directly connected); r is an aromatic ring derivative or alkyl or other groups. The invention designs and synthesizes a quinoline derivative with a novel structure, and the compound has a relieving effect on LPS-induced microglial cell inflammation and has a certain inhibition effect on cervical cancer cells.
Owner:HENAN UNIV OF SCI & TECH

Synthesis method of quinoline compound

The invention discloses a synthesis method of a quinoline compound, which comprises the following steps: carrying out [4 + 2] cyclization reaction on a compound 1 and a compound 2 in an organic solvent at 90-110 DEG C, and purifying to obtain the target quinoline compound. According to the method disclosed by the invention, the intermediate is generated from enaminone under a high-temperature condition, then the intermediate reacts with the reactant 1 to obtain a new intermediate, then the new intermediate is subjected to intermolecular cyclization and dehydration to obtain the target product, the reaction is green, no additive or catalyst is needed, and the reaction condition is mild.
Owner:JIANGNAN UNIV

A quinoline small molecule blended modified polymer dielectric material and a preparation method and application thereof

The application discloses a quinoline small molecule blended modified polymer dielectric material and a preparation method and application thereof, and belongs to the technical field of capacitor films. The preparation raw materials comprise quinoline derivatives, polymethyl methacrylate, styrene-methyl methacrylate copolymer, polyetherimide, polypropylene and N-methyl pyrrolidone solution, and the preparation steps comprise blending and film preparation. The blending solution or eutectic mixture is prepared through blending, and the polymer dielectric film is prepared through a flow casting method or bidirectional stretching. The prepared quinoline small molecule blended modified polymer dielectric film has excellent electrical properties, can reduce the leakage current of the polymer material, has high DC breakdown field strength, high energy storage density and low energy loss, and is easy to realize large-scale production.
Owner:XI AN JIAOTONG UNIV

Pyrrolo [3, 2, 1-ij] quinoline compound containing alkynyl full-carbon quaternary carbon center as well as preparation method and application of pyrrolo [3, 2, 1-ij] quinoline compound

The invention relates to the technical field of synthetic methods of heterocyclic skeletons, in particular to pyrrolo [3, 2, 1-ij] quinoline compounds containing alkynyl all-carbon quaternary carbon centers as well as a preparation method and application of the pyrrolo [3, 2, 1-ij] quinoline compounds. A preparation method of pyrrolo [3, 2, 1-ij] quinoline compounds containing alkynyl all-carbon quaternary carbon center comprises the following steps: placing an indole compound, an organic phosphine catalyst and potassium carbonate in a solvent to obtain a mixed solution, and reacting at the temperature of 60-80 DEG C for 1-2 hours to obtain the pyrrolo [3, 2, 1-ij] quinoline compounds. And then adding a beta '-acetoxymethyl allenoate compound into the mixed solution for cyclization reaction to obtain the pyrrolo [3, 2, 1-ij] quinoline compound containing the alkynyl full-carbon quaternary carbon center. The preparation method disclosed by the invention is simple to operate, the preparation cost is also remarkably reduced, and the use of a noble metal catalyst is effectively avoided, so that the application prospect of the pyrrolo [3, 2, 1-ij] quinoline compound in the field of medicines is widened.
Owner:YANCHENG INST OF TECH

Ru-ni bimetallic catalyst for selective hydrogenation of quinoline organic hydrogen storage carrier, and preparation method therefor and use thereof

The present invention relates to a Ru-Ni bimetallic catalyst for the selective hydrogenation of a quinoline organic hydrogen storage carrier, and a preparation method therefor and the use thereof. In the catalyst, carbon nitride is used as a carrier, and metal nanoparticles Ru and Ni serve as active components and are jointly loaded on the carbon nitride carrier; and the carbon nitride is prepared by mixing carbon tetrachloride, ethidene diamine and nano-silica, reacting same to obtain a carbon nitride polymer, then calcining same at 750-850ºC, performing a desilicification treatment, and then filtering and drying same. The catalyst provided in the present application has good catalytic hydrogenation performance in the selective hydrogenation of the quinoline organic hydrogen storage carrier and can achieve the omission of a solvent in a reaction system; the reaction is simple, green and environmentally friendly, and the gravimetric hydrogen storage density of the system can be maximally ensured when a quinoline compound is used as an organic hydrogen carrier; moreover, the catalyst also has a good cycling stability.
Owner:TIANFU YONGXING LAB +2

Quinoline compound and use thereof

Disclosed is a quinoline compound and a use thereof. A quinoline derivative of the present invention is a compound having phosphodiesterase 3A (PDE3A) inhibitory activity, has important potential therapeutic value, and is used in the treatment of cerebrovascular diseases or in dementia drugs.
Owner:NEURODAWN PHARM CO LTD

Aminoisoquinoline derivatives and their application in the preparation of antiviral drugs

This invention provides an aminoisoquinoline derivative and its application in the preparation of antiviral drugs. The invention reveals that the aminoisoquinoline derivative exhibits significant inhibitory effects against various RNA and DNA viruses, demonstrating broad-spectrum activity. This small-molecule inhibitor has low toxicity and does not affect the normal growth of host cells. It shows good antiviral efficacy even at low concentrations. The results of this invention indicate that the compound has the potential to be used in the preparation of antiviral drugs and has promising clinical application prospects.
Owner:WUHAN UNIV

Chloro pyrrolo [4, 3, 2-de] quinoline alkaloid as well as preparation method and application thereof

The invention relates to chloropyrrolo [4, 3, 2-de] quinoline alkaloids as well as a preparation method and application thereof. The structural formula of the quinoline alkaloid is shown in the specification. The obtained chloro-pyrrolo [4, 3, 2-de] quinoline alkaloids I-1-I-20 have anti-plant virus activity, and especially can inhibit tobacco mosaic virus and potato Y virus. The invention develops an efficient synthesis method of the pyrrolo [4, 3, 2-de] quinoline derivative, and lays a foundation for biological activity research of the pyrrolo [4, 3, 2-de] quinoline compound. # imgabs0 #
Owner:HEBEI UNIV OF TECH

Inhibitor containing quinoline derivative as well as preparation method and application thereof

The invention relates to an inhibitor containing quinoline derivatives as well as a preparation method and application of the inhibitor. In particular, the present invention relates to a compound containing quinoline derivatives, a preparation method thereof, a pharmaceutical composition containing the compound, and a use thereof in treatment of cancer diseases.
Owner:SHANGHAI HANSOH BIOMEDICAL CO LTD +1

A quinoline compound, preparation method and use and pharmaceutical composition thereof

The application belongs to the field of chemical medicines, and particularly relates to a quinoline compound, a preparation method and use thereof and a pharmaceutical composition thereof. The application provides a quinoline compound shown in formula I, which has excellent DNA methyltransferase 1 (DNMT1) inhibitory activity and good selectivity, can be used as a novel DNMT1 inhibitor, and provides a new option for drug development and application of diseases driven by DNMT1. Formula I.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Slo-1 modulators for prevention and / or treatment of a disease

The present invention relates to quinoline-based compounds. The compounds of the invention are suitable for the prevention and / or treatment of a disease such as a helminthic infection. The compounds of the invention are in particular suitable for the long-term prevention and / or treatment of a disease. Further, the invention relates to a pharmaceutical composition which can also be used to prevent and / or treat a disease, in particular in long-term.
Owner:ELANCO ANIMAL HEALTH GMBH +2

Isoquinoline medicine and application thereof in improvement or treatment of fungal infection

The invention relates to the technical field of small molecule drugs, in particular to an isoquinoline drug and application thereof to improvement or treatment of fungal infection. The isoquinoline medicine has good bacteriostatic activity on candida albicans, further research and observation of the compound have an inhibition effect on adhesion, hypha formation, biofilm formation, pathogenicity and the like of the candida albicans, and the result shows that the 10, 13-substituted berberine derivative can be used for preventing and / or treating fungal infection, especially candida albicans infection.
Owner:INST OF HEALTH & MEDICINE HEFEI COMPREHENSIVE NAT SCI CENT

A quinoline compound BBPQ7 and its preparation method and application

The present invention belongs to the technical field of pesticides and provides a quinoline compound and a preparation method and application thereof. The chemical structural formula of the quinoline compound is: #imgabs0#. Using tobacco mosaic virus as a test object, it is found that the compound has a very obvious inhibitory activity against plant pathogenic viruses and can be used as a new type of effective ingredient for resisting plant viruses.
Owner:JIANGXI AGRICULTURAL UNIVERSITY

Quinoline compounds as inhibitors of kras

Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.
Owner:INCYTE CORP

Environment-friendly weather-resistant handrail belt rubber material, preparation method, product and application

PendingCN122344357ARubber materialActive agent
The application belongs to the technical field of rubber, and particularly relates to an environment-friendly weather-resistant high-wear-resistance handrail belt rubber material and a preparation method thereof. The rubber material comprises, in terms of weight parts, 80-95 parts of styrene-butadiene rubber, 5-20 parts of butadiene rubber, 70-90 parts of carbon black, 6-9 parts of active agent, 3-5 parts of environment-friendly paraffin oil or naphthenic oil, 4-7 parts of anti-aging agent composition, 1-2 parts of accelerator and 1.5-2.5 parts of vulcanizing agent. The anti-aging agent composition is a combined system of p-phenylenediamine anti-aging agent and quinoline anti-aging agent. Through the synergistic effect of the rubber combined system, the gradation optimization of the reinforcing system and the synergistic effect of the anti-aging agent composition, the application simultaneously realizes high wear resistance, excellent weather resistance (ozone and thermal oxygen aging resistance), low-temperature toughness at-45 DEG C and environment-friendly performance of PAHs <= 10 ppm, and the comprehensive performance is significantly better than that of the existing handrail belt material, and the eight-year service life requirement of public places can be met.
Owner:TAICANG GUANLIAN POLYMERIC MATERIAL

Application of P2Y6R-targeted quinoline derivative in preparation of acute lung injury treatment and anti-inflammatory drugs

The invention provides an application of a quinoline derivative as shown in a formula (1) in preparation of drugs for treating acute lung injury and resisting inflammation. It is found for the first time that the quinoline derivative has the function of a P2Y6R antagonist, has an obvious antagonistic effect on P2Y6R-related inflammation and can be used for preparing P2Y6R-related anti-inflammatory drugs.
Owner:河南省儿童医院郑州儿童医院 +1

A composition containing quinoline TGF-β1 inhibitor and its use

The present invention belongs to the field of pharmaceutical preparations, and relates to a composition comprising a quinoline TGF-β1 inhibitor and its use, and specifically relates to a pharmaceutical composition comprising 4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)-7-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl)quinoline of formula (I) or a solvate or crystal thereof. The pharmaceutical composition provided by the present invention has complete dissolution, good stability, good absorption properties, high relative bioavailability,
Owner:NANJING SANHOME PHARMACEUTICAL CO LTD

Genetically engineered bacterium for catalytically generating quinoline compounds and application of genetically engineered bacterium

The invention discloses a genetically engineered bacterium for catalytically generating quinoline compounds and application of the genetically engineered bacterium. The genetically engineered bacterium expresses monoamine oxidase and an enzyme capable of catalyzing alcohol oxidation, and the enzyme capable of catalyzing alcohol oxidation is selected from alcohol oxidase or alcohol dehydrogenase. The invention accidentally finds that the monoamine oxidase coupled alcohol dehydrogenase or alcohol oxidase can catalyze the amino alcohol substrate to prepare the quinoline, and fills the blank that the amino alcohol substrate cannot be synthesized into the quinoline compound by the current biological catalysis method.
Owner:ZHEJIANG UNIV

Quinoline derivative containing piperazine structure as well as preparation method and application of quinoline derivative

The invention belongs to the technical field of pesticide chemistry, and relates to a quinoline derivative containing a piperazine structure and a preparation method and application thereof. The invention provides a quinoline derivative containing a piperazine structure, and the quinoline derivative has broad-spectrum inhibitory activity on phytopathogens such as plant pathogenic fungi, especially has excellent inhibitory activity on valsa mali, sclerotinia sclerotiorum, botrytis cinerea, gaeumannomyces graminis and magnaporthe oryzae. The bactericide is expected to be developed into a novel green bactericide which is efficient, safe, economical and environment-friendly.
Owner:SHENZHEN RESEARCH INSTITUTE OF NORTHWEST A & F UNIVERSITY